Johns Hopkins Diabetes Guide
Orlistat
INDICATIONS
FDA
FDA
- Xenical (Prescription Strength): Obesity management including weight loss and weight maintenance in patients with a body mass index (BMI) ≥ 30 kg/m2 OR ≥ 27 kg/m2 in the presence of other risk factors (eg, hypertension, diabetes, dyslipidemia).
- Alli (OTC Strength): Obesity management in overweight adults (18 years and older) when used along with a reduced-calorie and low-fat diet
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: June 4, 2019
Citation
Patel, Nisha K, et al. "Orlistat." Johns Hopkins Diabetes Guide, 2019. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547107/all/Orlistat.
Patel NK, Crowder A, Alavi R. Orlistat. Johns Hopkins Diabetes Guide. 2019. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547107/all/Orlistat. Accessed November 29, 2023.
Patel, N. K., Crowder, A., & Alavi, R. (2019). Orlistat. In Johns Hopkins Diabetes Guide https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547107/all/Orlistat
Patel NK, Crowder A, Alavi R. Orlistat [Internet]. In: Johns Hopkins Diabetes Guide. ; 2019. [cited 2023 November 29]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547107/all/Orlistat.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Orlistat
ID - 547107
A1 - Patel,Nisha,PharmD
AU - Crowder,Alona,Pharm.D.
AU - Alavi,Reza,M.D.
Y1 - 2019/06/04/
BT - Johns Hopkins Diabetes Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547107/all/Orlistat
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
